Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

• Myint Tin Tin Htar ,

  Contributed equally to this work with: Myint Tin Tin Htar, Anke L. Stuurman

  * E-mail: Myint.TinTinHtar@pfizer.com

  Affiliation Pfizer: Vaccines Clinical Epidemiology, Pfizer Inc, Paris, France

  ⨯
• Anke L. Stuurman ,

  Contributed equally to this work with: Myint Tin Tin Htar, Anke L. Stuurman

  Affiliation P95 Epidemiology and Pharmacovigilance Consulting and Services, P95, Leuven, Belgium

  ⨯
• Germano Ferreira,

  Affiliation P95 Epidemiology and Pharmacovigilance Consulting and Services, P95, Leuven, Belgium

  ⨯
• Cristiano Alicino,

  Affiliation Department of Health Sciences (DiSSal), University of Genoa, Genoa, Italy

  ⨯
• Kaatje Bollaerts,

  Affiliation P95 Epidemiology and Pharmacovigilance Consulting and Services, P95, Leuven, Belgium

  ⨯
• Chiara Paganino,

  Affiliation Department of Health Sciences (DiSSal), University of Genoa, Genoa, Italy

  ⨯
• Ralf René Reinert,

  Affiliation Pfizer: Vaccines Medical Development and Scientific Clinical Affairs, Pfizer Inc, Paris, France

  ⨯
• Heinz-Josef Schmitt,

  Affiliation Pfizer: Vaccines Medical Development and Scientific Clinical Affairs, Pfizer Inc, Paris, France

  ⨯
• Cecilia Trucchi,

  Affiliation Department of Health Sciences (DiSSal), University of Genoa, Genoa, Italy

  ⨯
• Thomas Vestraeten,

  Affiliation P95 Epidemiology and Pharmacovigilance Consulting and Services, P95, Leuven, Belgium

  ⨯
• Filippo Ansaldi

  Affiliation Department of Health Sciences (DiSSal), University of Genoa, Genoa, Italy

  ⨯